Bluelinea SA - Asset Resilience Ratio

Latest as of June 2025: 1.07%

Bluelinea SA (ALBLU) has an Asset Resilience Ratio of 1.07% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Bluelinea SA (ALBLU) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

€101.56K

≈ $118.73K USD Cash + Short-term Investments

Total Assets

€9.50 Million

≈ $11.10 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2012–2024)

This chart shows how Bluelinea SA's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see ALBLU asset base.

Liquid Assets Composition Over Time

This chart breaks down Bluelinea SA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore ALBLU strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€50.78K	0.53%
Short-term Investments	€50.78K	0.53%
Total Liquid Assets	€101.56K	1.07%

Asset Resilience Insights

Limited Liquidity: Bluelinea SA maintains only 1.07% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company maintains a balanced mix of cash and short-term investments.

Bluelinea SA Industry Peers by Asset Resilience Ratio

Compare Bluelinea SA's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Cochlear Ltd AU:COH	Medical Devices	9.76%
L&C Bio Co. Ltd KQ:290650	Medical Devices	2.14%
Eurobio Scientific SA PA:ALERS	Medical Devices	10.52%
Profound Medical Corp TO:PRN	Medical Devices	67.66%
EBR Systems Inc AU:EBR	Medical Devices	54.70%
Epitomee Medical Ltd TA:EPIT	Medical Devices	0.24%
Cleo Diagnostics Ltd AU:COV	Medical Devices	94.64%
Aligned Genetics Inc KQ:238120	Medical Devices	2.22%

Annual Asset Resilience Ratio for Bluelinea SA (2012–2024)

The table below shows the annual Asset Resilience Ratio data for Bluelinea SA.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	1.97%	€184.78K ≈ $216.03K	€9.38 Million ≈ $10.97 Million	-0.28pp
2023-12-31	2.24%	€243.38K ≈ $284.54K	€10.84 Million ≈ $12.67 Million	+0.98pp
2022-12-31	1.27%	€167.04K ≈ $195.28K	€13.16 Million ≈ $15.39 Million	-3.78pp
2021-12-31	5.05%	€407.64K ≈ $476.57K	€8.07 Million ≈ $9.44 Million	+0.54pp
2020-12-31	4.51%	€335.77K ≈ $392.55K	€7.44 Million ≈ $8.70 Million	+0.42pp
2019-12-31	4.09%	€283.59K ≈ $331.55K	€6.94 Million ≈ $8.11 Million	-1.09pp
2018-12-31	5.17%	€459.00K ≈ $536.61K	€8.87 Million ≈ $10.37 Million	-13.69pp
2014-12-31	18.86%	€1.06 Million ≈ $1.24 Million	€5.61 Million ≈ $6.56 Million	+9.18pp
2013-12-31	9.68%	€324.23K ≈ $379.06K	€3.35 Million ≈ $3.91 Million	-7.52pp
2012-12-31	17.20%	€603.10K ≈ $705.08K	€3.51 Million ≈ $4.10 Million	--

pp = percentage points

About Bluelinea SA

PA:ALBLU France Medical Devices

Market Cap

$3.00 Million

€2.57 Million EUR

Market Cap Rank

#29569 Global

#539 in France

Share Price

€0.14

Change (1 day)

-6.67%

52-Week Range

€0.14 - €0.63

All Time High

€6.30